Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐up

This publication has 37 references indexed in Scilit:

• Waning antibodies in measles and rubella vaccinees—a longitudinal study
  Vaccine, 2006
• Persistence of Vaccine-Induced Antibody to Measles 26–33 Years after Vaccination
  The Journal of Infectious Diseases, 2004
• Mumps and rubella eliminated from Finland.
  JAMA, 2000
• Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa
  The Lancet, 1999
• No measles in Finland
  The Lancet, 1997
• Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination
  Vaccine, 1997
• Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years
  The Pediatric Infectious Disease Journal, 1996
• Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus
  Vaccine, 1994
• RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLAND
  The Lancet, 1986
• Further-Attenuated Measles Vaccine: Characteristics and Use
  Clinical Infectious Diseases, 1983